BridgeBio Pharma, Inc. (BBIO)
78.30
+0.13
(+0.17%)
USD |
NASDAQ |
Nov 13, 16:00
78.29
-0.01
(-0.01%)
After-Hours: 19:59
BridgeBio Pharma Price : 78.30 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 78.60 | 79.12 | 77.58 | 78.30 | 1.149M |
| Nov 12, 2026 | 79.00 | 80.82 | 78.00 | 78.17 | 1.804M |
| Nov 11, 2026 | 78.86 | 79.75 | 77.80 | 79.54 | 2.325M |
| Nov 10, 2026 | 76.70 | 79.83 | 76.60 | 78.67 | 3.285M |
| Nov 09, 2026 | 74.58 | 78.06 | 73.49 | 77.93 | 3.000M |
| Nov 06, 2026 | 74.21 | 75.70 | 73.19 | 74.29 | 3.158M |
| Nov 05, 2026 | 77.90 | 78.58 | 74.11 | 74.27 | 3.384M |
| Nov 04, 2026 | 75.15 | 78.02 | 73.52 | 77.89 | 5.552M |
| Nov 03, 2026 | 75.48 | 76.79 | 73.95 | 74.03 | 2.479M |
| Nov 02, 2026 | 74.96 | 76.70 | 74.20 | 75.00 | 3.097M |
| Oct 30, 2026 | 72.85 | 75.85 | 71.90 | 74.95 | 5.771M |
| Oct 29, 2026 | 71.37 | 73.05 | 70.21 | 70.73 | 4.934M |
| Oct 28, 2026 | 69.10 | 71.18 | 68.65 | 70.82 | 3.112M |
| Oct 27, 2026 | 68.14 | 69.64 | 67.99 | 69.37 | 2.042M |
| Oct 26, 2026 | 68.56 | 68.83 | 67.86 | 68.15 | 2.059M |
| Oct 23, 2026 | 67.69 | 68.86 | 67.02 | 68.56 | 2.403M |
| Oct 22, 2026 | 67.48 | 69.32 | 67.07 | 68.12 | 2.780M |
| Oct 21, 2026 | 68.04 | 68.79 | 67.54 | 67.74 | 3.009M |
| Oct 20, 2026 | 68.28 | 69.00 | 67.25 | 67.55 | 2.733M |
| Oct 19, 2026 | 67.35 | 68.52 | 66.72 | 67.94 | 2.292M |
| Oct 16, 2026 | 67.03 | 67.04 | 65.26 | 66.39 | 2.056M |
| Oct 15, 2026 | 65.67 | 67.76 | 65.44 | 67.13 | 2.639M |
| Oct 14, 2026 | 63.34 | 65.36 | 62.86 | 64.94 | 2.702M |
| Oct 13, 2026 | 66.05 | 66.05 | 62.94 | 63.30 | 2.709M |
| Oct 12, 2026 | 65.35 | 66.42 | 65.20 | 65.75 | 1.779M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 165.04 |
| Ionis Pharmaceuticals, Inc. | 29.06 |
| Cytokinetics, Inc. | 56.13 |
| Pfizer Inc. | 28.89 |
| Ultragenyx Pharmaceutical, Inc. | 16.08 |
Price Related Metrics
| PS Ratio | 16.15 |
| Earnings Yield | -3.88% |
| Market Cap | 15.35B |